Market Overview:
The global NAD market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for dietary supplements and pharmaceuticals, and rising awareness about the benefits of NAD. Pharmaceutical grade accounted for the largest share of the global NAD market in 2017, owing to its high purity and superior quality. By application, dietary supplements accounted for the largest share of the global NAD market in 2017, followed by pharmaceuticals industry and other applications. North America was estimated to account for majority (36%) share of total revenue generated by Nad worldwide in 2017 while Europe held second place with 31%.
 Industry Outlook.svg)
Product Definition:
Nicotinamide Adenine Dinucleotide (NAD) is a coenzyme found in all living cells. It is important for the transfer of electrons between enzymes, and is also involved in the production of energy within cells. NAD can also be used as a medication to improve blood sugar control in people with type 2 diabetes.
Pharmaceutical Grade:
Pharmaceutical grade is a term used for products that are of the highest quality and purity. It's major application is in producing sirtuins, which are considered to be an important nutraceutical ingredient. They have several other applications such as anti-aging creams, cancer treatment drugs, etc.
Food grade:
Food-grade is a term used for products that are intended for human consumption. Food grade chemicals are not meant to be used as pesticides, herbicides or insecticides. They can be utilized in food supplements and functional foods but they should not be consumed directly.
Application Insights:
The other application segment includes the use of NAD in research activities and by biotechnology companies for producing various products such as vitamins, nutraceuticals, cosmetics and pharmaceutical drugs. The growing research activity on the bio-nucleotide is expected to boost demand over the forecast period.
Dietary supplements are expected to be one of the fastest-growing segments at a CAGR of XX% from 2018 to 2030 owing to increasing health consciousness among consumers coupled with rising aging population that requires additional nutritional intake for maintaining their health conditions. In addition, favorable government regulations related to safety standards are anticipated drive growth over the forecast period in this segment.
Pharmaceutical industry was estimated as one of the largest application segments with a share exceeding 35% in 2017 owing to high usage NAD by drug manufacturers for developing medicines and medical applications across all regions including North America, Europe, Asia Pacific and Middle East & Africa countries.
Regional Analysis:
North America was the largest regional market in 2017 owing to high demand for NAD from various end-use industries. The region is expected to maintain its dominance over the forecast period due to increasing geriatric population, coupled with rising awareness about nutritional products. Asia Pacific is estimated to be the fastest-growing regional market at a CAGR of XX% from 2018 to 2030 owing an increase in health consciousness and rise in disposable income levels among people.
The product has been observed effective against cancer cells as well as other diseases such as diabetes, Parkinson’s disease, & HIV infection; hence it attracts huge attention among researchers around the world looking for new drug targets & leads optimization activities on this molecule (nicotinamide).
Growth Factors:
- Increasing awareness about the benefits of NAD for overall health and well-being is expected to drive the market growth.
- Growing demand for anti-aging products and therapies is anticipated to boost the NAD market growth.
- Rising incidence of chronic diseases such as cancer, diabetes, and Alzheimer's is projected to fuel the demand for NAD therapies over the forecast period.
- Increasing research activities on novel applications of NAD in therapeutics are expected to create new opportunities for market growth during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nicotinamide Adenine Dinucleotide (NAD) Market Research Report
By Type
Pharmaceutical Grade, Food grade, Other
By Application
Dietary Supplement, Pharmaceutical Industry, Other
By Companies
EnzymeWorks, Bontac Bio-engineering, Hubei Widely Chemical Technology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
154
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Nicotinamide Adenine Dinucleotide (NAD) Market Report Segments:
The global Nicotinamide Adenine Dinucleotide (NAD) market is segmented on the basis of:
Types
Pharmaceutical Grade, Food grade, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dietary Supplement, Pharmaceutical Industry, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- EnzymeWorks
- Bontac Bio-engineering
- Hubei Widely Chemical Technology
 Market Overview.svg)
Highlights of The Nicotinamide Adenine Dinucleotide (NAD) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pharmaceutical Grade
- Food grade
- Other
- By Application:
- Dietary Supplement
- Pharmaceutical Industry
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nicotinamide Adenine Dinucleotide (NAD) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
NAD is a molecule that helps the body convert food into energy. NAD is found in all cells of the body and helps to create ATP, which provides energy for activities like breathing and moving muscles.
Some of the major companies in the nicotinamide adenine dinucleotide (nad) market are EnzymeWorks, Bontac Bio-engineering, Hubei Widely Chemical Technology.
The nicotinamide adenine dinucleotide (nad) market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nicotinamide Adenine Dinucleotide (NAD) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nicotinamide Adenine Dinucleotide (NAD) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nicotinamide Adenine Dinucleotide (NAD) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nicotinamide Adenine Dinucleotide (NAD) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nicotinamide Adenine Dinucleotide (NAD) Market Size & Forecast, 2020-2028
4.5.1 Nicotinamide Adenine Dinucleotide (NAD) Market Size and Y-o-Y Growth
4.5.2 Nicotinamide Adenine Dinucleotide (NAD) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Pharmaceutical Grade
5.2.2 Food grade
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Dietary Supplement
6.2.2 Pharmaceutical Industry
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nicotinamide Adenine Dinucleotide (NAD) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nicotinamide Adenine Dinucleotide (NAD) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Pharmaceutical Grade
9.6.2 Food grade
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Dietary Supplement
9.10.2 Pharmaceutical Industry
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Pharmaceutical Grade
10.6.2 Food grade
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Dietary Supplement
10.10.2 Pharmaceutical Industry
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Pharmaceutical Grade
11.6.2 Food grade
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Dietary Supplement
11.10.2 Pharmaceutical Industry
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Pharmaceutical Grade
12.6.2 Food grade
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Dietary Supplement
12.10.2 Pharmaceutical Industry
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Pharmaceutical Grade
13.6.2 Food grade
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Dietary Supplement
13.10.2 Pharmaceutical Industry
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nicotinamide Adenine Dinucleotide (NAD) Market: Competitive Dashboard
14.2 Global Nicotinamide Adenine Dinucleotide (NAD) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 EnzymeWorks
14.3.2 Bontac Bio-engineering
14.3.3 Hubei Widely Chemical Technology
